Wintermute Biomedical is an antimicrobials-focused pharmaceutical company located in Melbourne, Australia and Missoula, Montana. We have developed a novel platform for harnessing the antimicrobial activity of fatty acids, with a focus on developing a next-generation treatment for Shingles. Our lead product Solexan™ is now in clinical trials. Our vision is to make Solexan™ available for the millions of people who fall victim to Shingles each year.
Wintermute Biomedical is an antimicrobials-focused pharmaceutical company located in Melbourne, Australia and Missoula, Montana. We have developed a novel platform for harnessing the antimicrobial activity of fatty acids, with a focus on developing a next-generation treatment for Shingles. Our lead product Solexan™ is now in clinical trials. Our vision is to make Solexan™ available for the millions of people who fall victim to Shingles each year.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- City
- Melbourne
- Region
- Victoria
- Postal Code
- Country
- Australia